Канал: Nigerian Optometric Association

Lagos 2020 NOA AGM Expo

Lagos 2020 NOA AGM Expo

2019 NOA Conference

2019 NOA Conference

4.5 Key design elements in RCTs

4.5 Key design elements in RCTs

4.3 Main features of RCTs

4.3 Main features of RCTs

4 2 Epidemiology of the glaucomas

4 2 Epidemiology of the glaucomas

3 6 Calculating association between exposure and outcome

3 6 Calculating association between exposure and outcome

3.5 Error in cohort studies

3.5 Error in cohort studies

3.4 Identifying the population in a DR cohort study

3.4 Identifying the population in a DR cohort study

3.2 The challenge of diabetic retinopathy

3.2 The challenge of diabetic retinopathy

2 5 Calculating the association between disease and exposure

2 5 Calculating the association between disease and exposure

2.4 Recall and observer bias

2.4 Recall and observer bias

2.3 Selection and sources of cases and controls

2.3 Selection and sources of cases and controls

2.2 The epidemiology of AMD

2.2 The epidemiology of AMD

1.8 Confounding factors and outcomes in cross sectional studies

1.8 Confounding factors and outcomes in cross sectional studies

1.7 Strengths and weaknesses of rapid assessment

1.7 Strengths and weaknesses of rapid assessment

1.4 Cross sectional study for cataract

1.4 Cross sectional study for cataract

1.3 The epidemiology of cataract

1.3 The epidemiology of cataract

1.1 Welcome to the course and lesson 1

1.1 Welcome to the course and lesson 1

3.10 Conclusion and next steps

3.10 Conclusion and next steps

3 8 What is confounding

3 8 What is confounding

3.6 What is bias

3.6 What is bias

3 5 Other study designs

3 5 Other study designs

3 4 Linking research questions and methods Part 2

3 4 Linking research questions and methods Part 2

3 3 Cross sectional studies

3 3 Cross sectional studies

3 2 Linking research questions and methods Part 1

3 2 Linking research questions and methods Part 1

2 4 The effect of exposure on incidence

2 4 The effect of exposure on incidence

2 3 How to calculate incidence

2 3 How to calculate incidence

2 2 What is incidence in epidemiology

2 2 What is incidence in epidemiology

1 9 The Global Action Plan and VISION 2020

1 9 The Global Action Plan and VISION 2020

1 8 Epidemiology of visual impairment

1 8 Epidemiology of visual impairment

1 6 Defining visual impairment

1 6 Defining visual impairment

1 5 An introduction to prevalence

1 5 An introduction to prevalence

1 4 An introduction to epidemiology

1 4 An introduction to epidemiology

1 1 Welcome to the course

1 1 Welcome to the course

Delivering a mobile outreach DR service

Delivering a mobile outreach DR service

Planning services in low resource settings

Planning services in low resource settings

Different treatment options for diabetic eye disease

Different treatment options for diabetic eye disease

Making treatment decisions

Making treatment decisions

Monitoring diabetic retinopathy programmes

Monitoring diabetic retinopathy programmes

Setting up screening Practical issues

Setting up screening Practical issues

Call and recall Who does what and when on the screening pathway

Call and recall Who does what and when on the screening pathway

Grading diabetic retinopathy - Who can do it

Grading diabetic retinopathy - Who can do it

Who is involved in screening

Who is involved in screening

Working in partnership with diabetologists

Working in partnership with diabetologists

Planning DR services Where to begin

Planning DR services Where to begin

Systematic screening in the UK What have we learned

Systematic screening in the UK What have we learned

Understanding the barriers to diabetic retinopathy services

Understanding the barriers to diabetic retinopathy services

What screening tests are available

What screening tests are available

Identifying a good screening test sensitivity, specificity and coverage

Identifying a good screening test sensitivity, specificity and coverage

Principles of screening for diabetic retinopathy

Principles of screening for diabetic retinopathy

Welcome to lesson three

Welcome to lesson three

Diabetic retinopathy Implications for the health care sector

Diabetic retinopathy Implications for the health care sector

Risk factors and diabetic retinopathy progression

Risk factors and diabetic retinopathy progression

Vision threatening diabetic eye disease

Vision threatening diabetic eye disease

The global challenge of diabetes

The global challenge of diabetes

Introducing diabetes, sugar & insulin

Introducing diabetes, sugar & insulin

1 1 Welcome to the course

1 1 Welcome to the course